companydata.dkcompanydata.dk

2care4 Generics ApS: Financial statements 2018

CVR: 36960566

Source: annual report 2018, Danish Business Authority

01/01/201831/12/2018

2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,260,793 and a net result of DKK -2,896,734 compared with DKK -6,026,345 the year before. Equity in the 2018 report amounted to DKK 433,664. The solvency ratio was 2%. The company had 7 employees in the financial year.

Gross Profit
DKK 3,260,793
Profit/Loss
DKK -2,896,734
Equity
DKK 433,664
Total Assets
DKK 21,273,048
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-3.3 mio.-2.9 mio.434 t.7
2017--1.5 mio.-6 mio.330 t.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

2care4 Generics ApS appoints new auditorAug 31, 2018

As of August 31, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of 2care4 Generics ApS.

Auditor steps down at 2care4 Generics ApSAug 31, 2018

As of August 31, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of 2care4 Generics ApS.

2care4 Generics ApS: The 2017 annual report is outJun 1, 2018

2care4 Generics ApS has published its annual report for 2017. Gross profit came to DKK -1,519,397, and the net result was DKK -6,026,345.

Torben Børsting joins the board of 2care4 Generics ApSFeb 12, 2018

As of February 12, 2018, Torben Børsting has joined the board of directors of 2care4 Generics ApS.

Henrik Fomsgaard-Knudsen leaves the board of 2care4 Generics ApSFeb 12, 2018

As of February 12, 2018, Henrik Fomsgaard-Knudsen has left the board of directors of 2care4 Generics ApS.

Toke Værndal joins 2care4 Generics ApS as adm. dir.Feb 12, 2018

As of February 12, 2018, Toke Værndal is registered as adm. dir. of 2care4 Generics ApS.

Torben Børsting joins 2care4 Generics ApS as directorFeb 12, 2018

As of February 12, 2018, Torben Børsting is registered as director of 2care4 Generics ApS.

Henrik Fomsgaard-Knudsen steps down as adm. dir. of 2care4 Generics ApSFeb 12, 2018

As of February 12, 2018, Henrik Fomsgaard-Knudsen has stepped down as adm. dir. of 2care4 Generics ApS.

About 2care4 Generics ApS

2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.

Source: annual report 2025, Danish Business Authority